Express Scripts Holding Upgraded to Buy by Thomson Reuters/Verus (ESRX)
Express Scripts Holding (NASDAQ:ESRX) was upgraded by investment analysts at Thomson Reuters/Verus from a “hold” rating to a “buy” rating in a note issued to investors on Monday, American Banking News reports.
Other equities research analysts have also recently issued reports about the stock. Analysts at FBR & Co. upgraded shares of Express Scripts Holding from a “market perform” rating to an “outperform” rating in a research note to investors on Thursday. Separately, analysts at FBR Capital Markets initiated coverage on shares of Express Scripts Holding in a research note to investors on Thursday. They set an “outperform” rating and a $75.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Express Scripts Holding in a research note to investors on Tuesday, September 3rd. They now have a $67.00 price target on the stock. Five analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $69.89.
Shares of Express Scripts Holding (NASDAQ:ESRX) traded up 0.57% during mid-day trading on Monday, hitting $61.23. The stock had a trading volume of 2,136,594 shares. Express Scripts Holding has a 52 week low of $49.79 and a 52 week high of $67.66. The stock’s 50-day moving average is $65.13 and its 200-day moving average is $61.71. The company has a market cap of $49.339 billion and a P/E ratio of 27.37. Express Scripts Holding also was the target of some unusual options trading activity on Friday. Investors purchased 31,850 call options on the company. This is an increase of 538% compared to the average daily volume of 4,995 call options.
Express Scripts Holding (NASDAQ:ESRX) last released its earnings data on Friday, October 25th. The company reported $1.08 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.08. The company had revenue of $25.92 billion for the quarter, compared to the consensus estimate of $25.01 billion. During the same quarter last year, the company posted $1.02 earnings per share. Express Scripts Holding’s revenue was down 3.2% compared to the same quarter last year. Analysts expect that Express Scripts Holding will post $4.32 EPS for the current fiscal year.
Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.